Lobular Carcinoma in Situ: What Clinicians Need to Know
- 15 June 1993
- journal article
- Published by Taylor & Francis in Hospital Practice
- Vol. 28 (6) , 122-130
- https://doi.org/10.1080/21548331.1993.11442810
Abstract
The essential point is that LCIS cells are not likely to progress to invasive cancer. Rather, they represent breast tissue that is predisposed to cancer. Management thus emphasizes close follow-up.Keywords
This publication has 8 references indexed in Scilit:
- Non-invasive breast carcinomaBreast Cancer Research and Treatment, 1992
- The Continuing Dilemma of Lobular Carcinoma In SituArchives of Surgery, 1992
- Lobular Carcinoma in Situ: Pathology and TreatmentSurgical Clinics of North America, 1990
- The Treatment of in Situ Breast CancerActa Oncologica, 1989
- Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 yearsThe American Journal of Surgical Pathology, 1978
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breastCancer, 1978
- Lobular carcinomain Situ of the breast:An approach to rational treatmentCancer, 1977
- Lobular carcinoma in situ of the breast(Long-term followupCancer, 1974